The inhibitory effect of boric acid on hypoxia-regulated tumour-associated carbonic anhydrase IX

References

• a) Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nature Rev Drug Discov 2008;7:168–81. b) Supuran CT. Novel carbonic anhydrase inhibitors. Future Med Chem 2021;13:1935–7.
   PubMed Web of Science ®Google Scholar
• a) Mishra CB, Tiwari M, Supuran CT. Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: where are we today? Med Res Rev 2020;40:2485–565. b) Nocentini A, Angeli A, Carta F, et al. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. J Enzyme Inhib Med Chem 2021;36:561–80.
   PubMed Web of Science ®Google Scholar
• Chafe SC, Vizeacoumar FS, Venkateswaran G, et al. Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors. Sci Adv 2021;7:eabj0364.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors. Expert Opin Investig Drugs 2021;30:1197–208.
   PubMed Web of Science ®Google Scholar
• Biagiotti G, Angeli A, Giacomini A, et al. Glyco-coated CdSe/ZnS quantum dots as nanoprobes for carbonic anhydrase IX imaging in cancer cells. ACS Appl Nano Mater 2021;4:14153–60.
   PubMed Web of Science ®Google Scholar
• a) Cazzamalli S, Dal Corso A, Neri D. Acetazolamide serves as selective delivery vehicle for Dipeptide-linked drugs to renal cell carcinoma. Mol Cancer Ther 2016;15:2926–35. b) Teicher BA, Liu SD, Liu JT, et al. A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. Anticancer Res 1993;13:1549–56.c) Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011;10:767–77.
   PubMed Web of Science ®Google Scholar
• a) Supuran CT. Emerging role of carbonic anhydrase inhibitors. Clin Sci (Lond) 2021;135:1233–49. b) Angeli A, Carta F, Nocentini A, et al. Carbonic anhydrase inhibitors targeting metabolism and tumor microenvironment. Metabolites 2020;10:412.c) Zimmerman SA, Ferry JG, Supuran CT. Inhibition of the archaeal beta-class (Cab) and gamma-class (Cam) carbonic anhydrases. Curr Top Med Chem 2007;7:901–8.
   PubMed Web of Science ®Google Scholar
• a) Ruan K, Song G, Ouyang G. Role of hypoxia in the hallmarks of human cancer. J Cell Biochem 2009;107:1053–62. b) McDonald PC, Chafe SC, Brown WS, et al. Regulation of pH by carbonic anhydrase 9 mediates survival of pancreatic cancer cells with activated KRAS in response to hypoxia. Gastroenterology 2019;157:823–37.c) Swayampakula M, McDonald PC, Vallejo M, et al. The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion. Oncogene 2017;36:6244–61.
   PubMed Web of Science ®Google Scholar
• a) Supuran CT. Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin Drug Discov 2017;12:61–88. b) Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467–74.c) Supuran CT. How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem 2016;31:345–60.d) De Simone G, Supuran CT. (In)organic anions as carbonic anhydrase inhibitors. J Inorg Biochem 2012;111:117–29.e) Fiore A, Supuran C, Simone G. Are carbonic anhydrase inhibitors suitable for obtaining antiobesity drugs? Curr Pharm Des 2008;14:655–60.f) Sarikaya SB, Gülçin I, Supuran CT. Carbonic anhydrase inhibitors: inhibition of human erythrocyte isozymes I and II with a series of phenolic acids. Chem Biol Drug Des 2010;75:515–20.
   PubMed Web of Science ®Google Scholar
• a)McDonald PC, Chia S, Bedard PL, et al. A phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumors. Am J Clin Oncol 2020; 43:484–90. b) Angeli A, Carta F, Nocentini A, et al. Response to perspectives on the classical enzyme carbonic anhydrase and the search for inhibitors. Biophys J 2021;120:178–81.c) Supuran CT. Experimental carbonic anhydrase inhibitors for the treatment of hypoxic tumors. J Exp Pharmacol 2020;12:603–17.d) Huo Z, Bilang R, Supuran CT, et al. Perfusion-based bioreactor culture and isothermal microcalorimetry for preclinical drug testing with the carbonic anhydrase inhibitor SLC-0111 in patient-derived neuroblastoma. Int J Mol Sci 2022;23:3128.e) Alterio V, Kellner M, Esposito D, et al. Biochemical and structural insights into carbonic anhydrase XII/Fab6A10 complex. J Mol Biol 2019;431:4910–21.f) Testa C, Papini AM, Zeidler R, et al. First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors. J Enzyme Inhib Med Chem 2022;37:592–6.
   PubMed Web of Science ®Google Scholar
• Lopalco A, Lopedota AA, Laquintana V, et al. Boric acid, a lewis acid with unique and unusual properties: formulation implications. J Pharm Sci 2020;109:2375–86.
   PubMed Web of Science ®Google Scholar
• a) Winum JY, Innocenti A, Scozzafava A, et al. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isoforms I and II and transmembrane, tumor-associated isoforms IX and XII with boronic acids. Bioorg Med Chem 2009;17:3649–52. b) Vullo D, Milos M, Galic B, et al. Dipotassium-trioxohydroxytetrafluorotriborate, K2[B3O3F4OH], is a potent inhibitor of human carbonic anhydrases. J Enzyme Inhib Med Chem 2015;30:341–4.c) Pojskic L, Haveric S, Lojo-Kadric N, et al. Effects of dipotassium-trioxohydroxytetrafluorotriborate, K2[B3O3F4OH], on cell viability and gene expression of common human cancer drug targets in a melanoma cell line. J Enzyme Inhib Med Chem 2016;31:999–1004.d) Supuran CT. Bortezomib inhibits mammalian carbonic anhydrases. Bioorg Med Chem 2017;25:5064–7.e) Nocentini A, Supuran CT, Winum JY. Benzoxaborole compounds for therapeutic uses: a patent review (2010–2018). Expert Opin Ther Pat 2018;28:493–504.
   PubMed Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561–73.
   PubMed Web of Science ®Google Scholar
• Kuphal S, Winklmeier A, Warnecke C, Bosserhoff AK. Constitutive HIF-1 activity in malignant melanoma. Eur J Canc 2010;46:1159–69.
   PubMed Web of Science ®Google Scholar
• Jenkins RW, Fisher DE. Treatment of advanced melanoma in 2020 and beyond. J Invest Dermatol 2021;141:23–31.
   PubMed Web of Science ®Google Scholar
• Lannagan TR, Jackstadt R, Leedham SJ, Sansom OJ. Advances in colon cancer research: in vitro and animal models. Curr Opin Gen Dev 2021;66:50–6.
   PubMed Web of Science ®Google Scholar
• Cui Y, Winton MI, Zhang ZF, et al. Dietary boron intake and prostate cancer risk. Oncol Rep 2004;11:887–92.
   PubMed Web of Science ®Google Scholar
• Gallardo-Williams MT, Maronpot RR, Wine RN, et al. Inhibition of the enzymatic activity of prostate-specific antigen by boric acid and 3-nitrophenyl boronic acid. Prostate 2003;54:44–9.
   PubMed Web of Science ®Google Scholar
• Barranco WT, Eckhert CD. Boric acid inhibits human prostate cancer cell proliferation. Cancer Lett 2004;216:21–9.
   PubMed Web of Science ®Google Scholar
• a) Meacham SL, Elwell KE, Ziegler S, Carper SW. Boric acid inhibits cell growth in breast and prostate cancer cell lines. Advances in plant and animal boron nutrition. Berlin, Germany: Springer Science & Business Media; 2007:299–306.
   Google Scholar
  b) Elegbede AF. Boric acid inhibits cell growth and induces apoptosis in breast cancer cells [ProQuest dissertations and theses]. 2007. 69 p.
   Google Scholar
• Al-Ali R, Gonzalez-Sarmiento R. High concentrations of boric acid induce autophagy in cancer cell lines. bioRxiv 2017;1–9.
   Google Scholar
• Tureyen A, Gunay S, Erden Y, Ince S. Effect of boric acid in colorectal adenocarcinoma cell line and role on chemotherapeutic effect of 5-fluorouracil. Int J Pharmacol 2021;17:57–64.
   Google Scholar
• Acerbo AS, Miller LM. Assessment of the chemical changes induced in human melanoma cells by boric acid treatment using infrared imaging. Analyst 2009;134:1669–74.
   PubMed Web of Science ®Google Scholar